The world’s vaccines have a rich history, rooted from ancient traditions to modern innovation. Since the 10th century, the practice of variolation in China and the Middle East began to be used to prevent smallpox. In 1796, Edward Jenner developed the first smallpox vaccine using the vaccinia virus, which was an important milestone in the field of immunology. Vaccine development continued, and in the 19th century, Louis Pasteur made a major breakthrough with the principle of microbial attenuation through rabies and anthrax vaccines. These vaccines reinforce the concept of active immunization. In the early 20th century, many new vaccines began to be developed, including diphtheria and tetanus vaccines, which in fact saved millions of lives. The revolution in vaccines continued until the mid-20th century, when the WHO-led Global Vaccination Program was launched. The polio vaccine, developed by Jonas Salk and Albert Sabin, became one of the greatest successes in vaccination history, reducing the incidence of polio by more than 99%. Entering the 21st century, vaccine technology innovation has experienced significant progress. mRNA-based vaccines became a major concern during the emergence of the COVID-19 pandemic. Pfizer-BioNTech and Moderna are pioneers in the use of this technology, demonstrating the efficiency and speed of vaccine production. This innovation also paves the way for the development of vaccines for other viruses, such as HIV and influenza. As part of public health education, it is important that individuals understand the need for vaccination. Vaccines not only protect individuals but also contribute to herd immunity, which is key to preventing disease outbreaks. Various awareness campaigns have been launched to overcome vaccine hesitancy and increase global vaccination rates. On the other hand, vaccine challenges remain, including uneven distribution and the emergence of new variants of the pathogen. International collaborations, such as COVAX, seek to ensure equitable access to vaccines for low- and middle-income countries. The development of more efficient and targeted vaccines is the focus of current research and development. Vaccines also face challenges from misinformation and skepticism. Therefore, effective and transparent communication from health agencies is critical to building public trust. With advances in research and technology, the future of vaccines looks promising, driving innovation that can continue to save lives around the world. In a broader context, the pharmaceutical sector is faced with new directions in vaccine research. Recent trends involve the development of therapeutic vaccines that not only prevent infections but also treat existing diseases. Data and experience during the pandemic provide valuable lessons to accelerate innovation and vaccine development in the future.